电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Keratin 5/8 抗体

This anti-Keratin 5/8 antibody is a 小鼠 单克隆 antibody detecting Keratin 5/8 in WB, FACS, IHC, ICC 和 IHC (fro). Suitable for 人, 小鼠, 大鼠 和 兔.
产品编号 ABIN344026
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Keratin 5/8 抗体 (ABIN344026)

抗原

Keratin 5/8 (KRT5/8)

适用

  • 24
  • 17
  • 16
  • 14
  • 14
  • 14
  • 13
  • 11
  • 10
  • 3
  • 2
  • 2
人, 小鼠, 大鼠, 兔

宿主

  • 24
小鼠

克隆类型

  • 24
单克隆

标记

  • 10
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Keratin 5/8 antibody is un-conjugated

应用范围

  • 17
  • 16
  • 14
  • 13
  • 8
  • 8
  • 6
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • 特异性

    Specific for cytokeratin 5 and cytokeratin 8. Recognizes virtually all epithelial tissues and carcinomas. Human, mouse, rat, hamster, rabbit, canine and porcine. Has not been tested on other species.

    纯化方法

    Purified

    免疫原

    Cytokeratins from the human lung cancer cell line MR21.

    Type of Immunogen: Cells

    亚型

    IgG1
  • 应用备注

    Approved: Flo, ICC, IHC, IHC-Fr, WB

    Usage: Western blot. Immunohistochemistry on frozen tissue sections. Immunocytochemistry. Flow cytometry.

    说明

    Target Species of Antibody: Human

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    Lot specific

    缓冲液

    Buffer, 0.1 % sodium azide.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • 抗原

    Keratin 5/8 (KRT5/8)

    别名

    Cytokeratin 5+8

    背景

    This antibody detects: Cytokeratin 5+8
You are here: